Weighted logistic regression models of associations with high burnout
. | Total respondents (n = 411), adjusted OR (95% CI) . |
---|---|
Work hr per wk | |
High work hr (top quartile) | 2.14 (0.68-6.73) |
High work at home hr (top quartile) | 0.87 (0.40-1.87) |
Calls per yr | |
High weeknight call (top quartile) | 0.49 (0.15-1.62) |
High weekend call (top quartile) | 0.99 (0.33-2.92) |
Often work with APPs | 0.40∗ (0.20-0.80) |
Use of e-consults and/or telemedicine tools | 1.83 (0.82-4.08) |
Mentoring of students or trainees | |
Any mentoring | 0.75 (0.33-1.69) |
Research | |
Any research | 0.52 (0.22-1.22) |
Compensation models | |
RVU-only | 4.37∗ (2.00-9.58) |
RVU + salary | 1.06 (0.41-2.75) |
Salary-only + other (reference) | — |
Sex | |
Female | 2.56† (1.24-5.28) |
Age, yr | |
≤40 | 0.23† (0.07-0.80) |
41-55 (reference) | — |
≥56 | 0.69 (0.33-1.46) |
Yr in current job | |
≥10 | 1.52 (0.71-3.30) |
Race/ethnicity | |
Underrepresented in medicine | 1.56 (0.34-7.07) |
Clinical focus | |
Benign hematology | 0.86 (0.23-3.22) |
Malignant hematology | 0.82 (0.19-3.57) |
Solid tumor oncology | 1.55 (0.70-3.43) |
Combination or other (reference) | — |
. | Total respondents (n = 411), adjusted OR (95% CI) . |
---|---|
Work hr per wk | |
High work hr (top quartile) | 2.14 (0.68-6.73) |
High work at home hr (top quartile) | 0.87 (0.40-1.87) |
Calls per yr | |
High weeknight call (top quartile) | 0.49 (0.15-1.62) |
High weekend call (top quartile) | 0.99 (0.33-2.92) |
Often work with APPs | 0.40∗ (0.20-0.80) |
Use of e-consults and/or telemedicine tools | 1.83 (0.82-4.08) |
Mentoring of students or trainees | |
Any mentoring | 0.75 (0.33-1.69) |
Research | |
Any research | 0.52 (0.22-1.22) |
Compensation models | |
RVU-only | 4.37∗ (2.00-9.58) |
RVU + salary | 1.06 (0.41-2.75) |
Salary-only + other (reference) | — |
Sex | |
Female | 2.56† (1.24-5.28) |
Age, yr | |
≤40 | 0.23† (0.07-0.80) |
41-55 (reference) | — |
≥56 | 0.69 (0.33-1.46) |
Yr in current job | |
≥10 | 1.52 (0.71-3.30) |
Race/ethnicity | |
Underrepresented in medicine | 1.56 (0.34-7.07) |
Clinical focus | |
Benign hematology | 0.86 (0.23-3.22) |
Malignant hematology | 0.82 (0.19-3.57) |
Solid tumor oncology | 1.55 (0.70-3.43) |
Combination or other (reference) | — |